Literature DB >> 15381636

Effect of overexpressed adenylyl cyclase VI on beta 1- and beta 2-adrenoceptor responses in adult rat ventricular myocytes.

Joalice C C Stark1, Stephen F Haydock, Roger Foo, Morris J Brown, Sian E Harding.   

Abstract

1. Adenylyl cyclase VI (ACVI) is one of the most abundantly expressed beta adrenergic receptor (betaAR)-coupled cyclases responsible for cyclic AMP (cAMP) production within the mammalian myocardium. We investigated the role of ACVI in the regulation of cardiomyocyte contractility and whether it is functionally coupled with beta(1) adrenergic receptor (beta(1)AR). 2. Recombinant adenoviruses were generated for ACVI and for antisense to ACVI (AS). Adult rat ventricular myocytes were transfected with ACVI virus, AS or both (SAS). Adenovirus for green fluorescent protein (GFP) served as control. Myocyte contraction amplitudes (% shortening) and relaxation times (R50) were analysed. ACVI function was determined using cAMP assays. 3. ACVI-transfected cells demonstrated a strong 139 kDa ACVI protein band compared to controls. ACVI myocytes had higher steady-state intracellular cAMP levels than GFP myocytes when unstimulated (GFP vs ACVI=6.60+/-0.98 vs 14.2+/-2.1 fmol cAMP/viable cell, n=4, P<0.05) and in the presence of 1 microm isoprenaline or 10 microm forskolin. 4. ACVI myocytes had increased basal contraction (% shortening: GFP vs ACVI: 1.90+/-1.36 vs 3.91+/-2.29, P<0.0001) and decreased basal R50 (GFP vs ACVI: 62.6+/-24.2 ms (n=50) vs 45.0+/-17.2 ms (n=248), P<0.0001). ACVI myocyte responses were increased for forskolin (E(max): GFP=6.70+/-1.59 (n=6); ACVI=9.06+/-0.69 (n=14), P<0.01) but not isoprenaline. 5. ACVI myocyte responses were increased (E(max): GFP vs ACVI=3.16+/-0.77 vs 5.10+/-0.60, P<0.0001) to xamoterol (a partial beta(1)AR-selective agonist) under beta(2)AR blockade (+50 nm ICI 118, 551). AS decreased both control and ACVI-stimulated xamoterol responses (E(max): AS=2.59+/-1.42, SAS=1.38+/-0.5). ACVI response was not mimicked by IBMX. Conversely, response through beta(2) adrenergic receptor (beta(2)AR) was decreased in ACVI myocytes. 6. In conclusion, ACVI overexpression constitutively increases myocyte contraction amplitudes by raising cAMP levels. Native ACVI did not contribute to basal cAMP production or contraction amplitude and only to a minor extent to the forskolin response. beta(1)AR but not beta(2)AR coupling was dependent on ACVI.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15381636      PMCID: PMC1575419          DOI: 10.1038/sj.bjp.0705976

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  40 in total

1.  Immunodetection of adenylyl cyclase protein in tissues.

Authors:  Y Ishikawa; B S Grant; S Okumura; C Schwencke; M Yamamoto
Journal:  Mol Cell Endocrinol       Date:  2000-04-25       Impact factor: 4.102

2.  Expression of adenylyl cyclase type IX and calcineurin in synapses of the central nervous system.

Authors:  S A Sosunov; S P Kemaikin; I A Kurnikova; F A Antoni; A A Sosunov
Journal:  Bull Exp Biol Med       Date:  2001-02       Impact factor: 0.804

3.  beta-Adrenergic pathway induces apoptosis through calcineurin activation in cardiac myocytes.

Authors:  S Saito; Y Hiroi; Y Zou; R Aikawa; H Toko; F Shibasaki; Y Yazaki; R Nagai; I Komuro
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

4.  Influence of beta1-adrenoceptor blockade on the gene expression of adenylate cyclase subtypes and beta-adrenoceptor kinase in human atrium.

Authors:  T Wang; M J Brown
Journal:  Clin Sci (Lond)       Date:  2001-09       Impact factor: 6.124

5.  Inhibition of spontaneous beta 2-adrenergic activation rescues beta 1-adrenergic contractile response in cardiomyocytes overexpressing beta 2-adrenoceptor.

Authors:  S J Zhang; H Cheng; Y Y Zhou; D J Wang; W Zhu; B Ziman; H Spurgoen; R J Lefkowitz; E G Lakatta; W J Koch; R P Xiao
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

6.  Characterisation of human adenylyl cyclase IX reveals inhibition by Ca(2+)/Calcineurin and differential mRNA plyadenylation.

Authors:  J M Paterson; S M Smith; J Simpson; O C Grace; A A Sosunov; J E Bell; F A Antoni
Journal:  J Neurochem       Date:  2000-10       Impact factor: 5.372

7.  Spontaneous activation of beta(2)- but not beta(1)-adrenoceptors expressed in cardiac myocytes from beta(1)beta(2) double knockout mice.

Authors:  Y Y Zhou; D Yang; W Z Zhu; S J Zhang; D J Wang; D K Rohrer; E Devic; B K Kobilka; E G Lakatta; H Cheng; R P Xiao
Journal:  Mol Pharmacol       Date:  2000-11       Impact factor: 4.436

8.  Receptor number and caveolar co-localization determine receptor coupling efficiency to adenylyl cyclase.

Authors:  R S Ostrom; C Gregorian; R M Drenan; Y Xiang; J W Regan; P A Insel
Journal:  J Biol Chem       Date:  2001-08-31       Impact factor: 5.157

9.  The effect of Gi-protein inactivation on basal, and beta(1)- and beta(2)AR-stimulated contraction of myocytes from transgenic mice overexpressing the beta(2)-adrenoceptor.

Authors:  H Gong; D L Adamson; H K Ranu; W J Koch; J F Heubach; U Ravens; O Zolk; S E Harding
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

10.  Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes.

Authors:  Manuela Zaccolo; Tullio Pozzan
Journal:  Science       Date:  2002-03-01       Impact factor: 47.728

View more
  3 in total

1.  Differential dopamine receptor subtype regulation of adenylyl cyclases in lipid rafts in human embryonic kidney and renal proximal tubule cells.

Authors:  Peiying Yu; Min Sun; Van Anthony M Villar; Yanrong Zhang; Edward J Weinman; Robin A Felder; Pedro A Jose
Journal:  Cell Signal       Date:  2014-07-15       Impact factor: 4.315

Review 2.  Molecular targets in heart failure gene therapy: current controversies and translational perspectives.

Authors:  Victor Kairouz; Larissa Lipskaia; Roger J Hajjar; Elie R Chemaly
Journal:  Ann N Y Acad Sci       Date:  2012-04       Impact factor: 6.499

3.  Approaches to High-Throughput Analysis of Cardiomyocyte Contractility.

Authors:  Peter T Wright; Sharmane F Tsui; Alice J Francis; Kenneth T MacLeod; Steven B Marston
Journal:  Front Physiol       Date:  2020-07-08       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.